It is also possible that this treatment could be applied to other types of cancers, including various familial cancers that are dependent on the insulin-regulated PI3K-Akt-mTOR pathway, and could represent the first effective prevention method that does not have adverse effects. This evidence concerns the gene INS and hereditary cancer.